Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis

Journal of Cellular Biochemistry

Volumn 88, Issue 2, 2003, Pages 209-215

  Riggs, B Lawrence ^a  

^a MAYO CLINIC   (United States)

Author keywords

1 hydroxyvitamin D; 1,25 dihydroxyvitamin D; Calcitriol; Calcium absorption; Estrogen

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; ESTROGEN; VITAMIN D;

AGED; AGING; CALCIUM ABSORPTION; CALCIUM INTAKE; CLINICAL TRIAL; CONFERENCE PAPER; ENDOCRINE SYSTEM; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FRACTURE; HUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

AGING; CALCIUM; ENDOCRINE SYSTEM; ESTROGENS; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0037302085     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10345     Document Type: Conference Paper

References (41)

1. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH. 1988. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401-408.
2. Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G. 1995. Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density. Calcif Tissue Int 57:161-162.
3. Bilezikian JP, Silverberg SJ. 2001. The role of parathyroid hormone and vitamin D in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Vol. 40. San Diego: Academic Press. pp 71-84.
4. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. 1992. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642.
5. Chen JT, Shiraki M, Hasumi K, Tanaka N, Katase K, Kato T, Hirai T, Nakamura T, Ogata E. 1997. 1-Alphahydroxyvitamin D-3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 20:557-562.
6. Eastell R, Riggs BL. 1997. Vitamin D and osteoporosis. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press. pp 695-711.
7. Eastell R, Yergey AL, Vieira N, Cedel SL, Kumar R, Riggs BL. 1991. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function and age in women: Evidence of an age-related intestinal resistance to 1,25(OH)2D action. J Bone Miner Res 6:125-132.
8. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. 1992. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: Relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 75:176-182.
9. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC, Jr. 1986. The influence of age on bone mineral regulating hormones. Bone 7:421-425.
10. Gallagher JC, Goldgar D. 1990. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: A randomized controlled study. Ann Intern Med 113:649-655.
11. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. 1979. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium. J Clin Invest 64:729-736.
12. Gallagher JC, Riggs BL, Recker RR, Goldgar D. 1989. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 191:287-292.
13. Gallagher JC, Fowler SE, Detter JR, Sherman SS. 2001. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618-3628.
14. Gennari C, Agnusdei D, Nardi P, Civitelli R. 1990. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab 71:1288-1293.
15. Horst RL, Goff JP, Reinhardt TA. 1990. Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor. Endocrinology 126:1053-1057.
16. Ireland P, Fordtran JS. 1973. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 52:2672-2681.
17. 3) on osteoporosis: multicenter double-blind study. J Clin Exp Med 123:958-973.
18. Johnston CC, Peacock M, Meunier PJ. 1987. Osteomalacia as a risk factor for hip fractures in the USA. In: Christiansen C, Johansen JS, Riis BJ, editors. Osteoporosis 1987, 1. Viborg, Denmark: Norhaven A/S. 317-320.
19. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. 1998. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266-2274.
20. Kinyamu HK, Gallagher JC, Petranick KM, Ryschon KL. 1996. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res 11:1400-1405.
21. Kinyamu HK, Gallagher JC, Prahl JM, Deluca HF, Petranick KM, Lanspa SJ. 1997. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25 dihydroxyvitamin D in normal young and elderly women. J Bone Miner Res 12:922-928.
22. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. 1994. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 79:211-216.
23. Lips P. 2001. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501.
24. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. 1996. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 124:400-406.
25. McKane WR, Khosla S, Burritt MF, Kao PC, Wilson DM, Ory SJ, Riggs BL. 1995. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause-a clinical research center study. J Clin Endocrinol Metab 80:3458-3464.
26. McKane RW, Khosla S, Risteli J, Robins SP, Muhs JM, Riggs BL. 1997. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Physicians 109:174-180.
27. Menczel J, Foldes J, Steinberg R, Leichter I, Shalita B, Bdolahabram T, Kadosh S, Mazor Z, Ladkani D. 1994. Alfacalcidol (Alpha D-3) and calcium in osteoporosis. Clin Orthop 300:241-247.
28. Ooms ME, Lips P, Roos JC, Van Der Vijgh W, Popp-Snijders C, Bezemer PD, Bouter LM. 1995. Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177-1184.
29. Orimo H, Shiraki M, Hayashi T, Nakamura T. 1987. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1alpha(OH)-vitamin D3. Bone Miner 3:47-52.
30. Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N. 1994. Effects of 1alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370-376.
31. Ott SM, Chesnut CH. 1989. Calcitriol treatment is not effective in postmenopausal osteoprosis. Ann Intern Med 110:267-274.
32. Ott SM, Chesnut CH. 1990. Tolerance to dose of calcitriol is associated with improved bone density in women with postmenopausal osteoporosis. J Bone Miner Res 5:S186.
33. Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O'Fallon WM, Khosla S. 2000. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: Evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 85:4023-4027.
34. Reid IR. 2001. Vitamin D and its metabolites in the management of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Vol. 68. San Diego: Academic Press. pp 553-575.
35. Riggs BL, Nelson KI. 1985. Effect of long-term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. J Clin Endocrinol Metab 61:457-461.
36. Riggs BL, Khosla S, Melton LJ III. 1998. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763-773.
37. Slovik DM, Neer RM, Potts JT, Jr. 1981. Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1261-1271.
38. Thomas ML, Xu X, Norfleet AM, Watson CS. 1993. The presence of functional estrogen receptors in intestinal epithelial cells. Endocrinology 132:426-430.
39. Tilyard MW, Spears GFS, Thomson J, Dovey S. 1992. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362.
40. Tsai K-S, Heath H III, Kumar R, Riggs BL. 1984s. Impaired vitamin D metabolism with aging in women: Possible role in pathogenesis of senile osteoporosis. J Clin Invest 73: 1668-1672.
41. Tsai K-S, Wahner HW, Offord KP, Melton LJ III, Kumar R, Riggs BL. 1987. Effect of aging on vitamin D stores and bone density in women. Calcif Tissue Int 40:241-243.